# A Study to Assess the Effect of Abiraterone Acetate in Male Participants With Mild or Moderate Hepatic Impairment Compared to Matched Control Participants With Normal Hepatic Function

> **NCT02001571** · PHASE1 · COMPLETED · sponsor: **Cougar Biotechnology, Inc.** · enrollment: 24 (actual)

## Conditions studied

- Prostate Cancer

## Interventions

- **DRUG:** Abiraterone acetate

## Key facts

- **NCT ID:** NCT02001571
- **Lead sponsor:** Cougar Biotechnology, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2009-08
- **Primary completion:** 2010-04
- **Final completion:** 2010-04
- **Target enrollment:** 24 (ACTUAL)
- **Last updated:** 2013-12-05


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT02001571

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT02001571, "A Study to Assess the Effect of Abiraterone Acetate in Male Participants With Mild or Moderate Hepatic Impairment Compared to Matched Control Participants With Normal Hepatic Function". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT02001571. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*